In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Verve Therapeutics Inc (NASDAQ: VERV) closed the day trading at $6.39 up 4.67% from the previous closing price of $6.10. In other words, the price has increased by $4.67 from its previous closing price. On the day, 2.34 million shares were traded.
Ratios:
For a better understanding of VERV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.84 and its Current Ratio is at 9.84. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.Canaccord Genuity initiated its Buy rating on April 13, 2023, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Kathiresan Sekar sold 9,822 shares for $4.15 per share. The transaction valued at 40,761 led to the insider holds 346,686 shares of the business.
Nickerson Joan sold 2,777 shares of VERV for $11,525 on Apr 02 ’25. The Chief Administrative Officer now owns 17,420 shares after completing the transaction at $4.15 per share. On Apr 02 ’25, another insider, Ashe Andrew D., who serves as the insider of the company, sold 2,681 shares for $4.15 each. As a result, the insider received 11,126 and left with 348,828 shares of the company.
Stock Price History:
Over the past 52 weeks, VERV has reached a high of $9.31, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is 37.62%, while the 200-Day Moving Average is calculated to be 12.28%.
Shares Statistics:
A total of 88.80M shares are outstanding, with a floating share count of 65.76M. Insiders hold about 26.23% of the company’s shares, while institutions hold 74.01% stake in the company.
